Search Count: 1
 |
Discovery And Clinical Validation Of Rly-4008, The First Highly Selective Fgfr2 Inhibitor With Activity Across Fgfr2 Alterations And Resistance Mutations
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:3.79 Å Release Date: 2023-06-07 Classification: TRANSFERASE/INHIBITOR Ligands: WCJ |